| Dr Thomas S Tooma, MD | |
|
3501 Jamboree Rd, Suite 1100, Newport Beach, CA 92660-2939 | |
| (949) 854-7400 | |
| (949) 854-7331 |
| Full Name | Dr Thomas S Tooma |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 45 Years |
| Location | 3501 Jamboree Rd, Newport Beach, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508980525 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | G42262 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Thomas S Tooma M D A Professional Corporation | 7911004288 | 27 |
News Archive
Differences in opinions between parents and children and executives of restaurant chains represent a challenge in terms of promoting healthy eating habits.
Salix Pharmaceuticals, Ltd. today announced the successful outcome of two Phase 3, randomized, double-blind, placebo-controlled, multicenter trials, TARGET 1 and TARGET 2, designed to evaluate the efficacy and safety of rifaximin 550 mg TID in the treatment of patients with non-constipation irritable bowel syndrome (non-C IBS).
Hearing sounds that are linked to positive experiences from the past can considerably increase well-being, reduce depressive moods and alleviate behavioral problems in people with memory loss, a study by the University of Zurich in cooperation with clinical partners has found.
Patients with two out of the three most common types of advanced breast cancer now have an average survival time of at least five years, according to a panel of experts at the Advanced Breast Cancer Sixth International Consensus Conference (ABC 6).
› Verified 3 days ago
| Entity Name | Thomas S Tooma M D A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922129865 PECOS PAC ID: 7911004288 Enrollment ID: O20070521000571 |
News Archive
Differences in opinions between parents and children and executives of restaurant chains represent a challenge in terms of promoting healthy eating habits.
Salix Pharmaceuticals, Ltd. today announced the successful outcome of two Phase 3, randomized, double-blind, placebo-controlled, multicenter trials, TARGET 1 and TARGET 2, designed to evaluate the efficacy and safety of rifaximin 550 mg TID in the treatment of patients with non-constipation irritable bowel syndrome (non-C IBS).
Hearing sounds that are linked to positive experiences from the past can considerably increase well-being, reduce depressive moods and alleviate behavioral problems in people with memory loss, a study by the University of Zurich in cooperation with clinical partners has found.
Patients with two out of the three most common types of advanced breast cancer now have an average survival time of at least five years, according to a panel of experts at the Advanced Breast Cancer Sixth International Consensus Conference (ABC 6).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas S Tooma, MD 3501 Jamboree Rd, Suite 1100, Newport Beach, CA 92660-2939 Ph: (949) 854-7400 | Dr Thomas S Tooma, MD 3501 Jamboree Rd, Suite 1100, Newport Beach, CA 92660-2939 Ph: (949) 854-7400 |
News Archive
Differences in opinions between parents and children and executives of restaurant chains represent a challenge in terms of promoting healthy eating habits.
Salix Pharmaceuticals, Ltd. today announced the successful outcome of two Phase 3, randomized, double-blind, placebo-controlled, multicenter trials, TARGET 1 and TARGET 2, designed to evaluate the efficacy and safety of rifaximin 550 mg TID in the treatment of patients with non-constipation irritable bowel syndrome (non-C IBS).
Hearing sounds that are linked to positive experiences from the past can considerably increase well-being, reduce depressive moods and alleviate behavioral problems in people with memory loss, a study by the University of Zurich in cooperation with clinical partners has found.
Patients with two out of the three most common types of advanced breast cancer now have an average survival time of at least five years, according to a panel of experts at the Advanced Breast Cancer Sixth International Consensus Conference (ABC 6).
› Verified 3 days ago
Dr. Michael Kermani, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1441 Avocado Ave, 501, Newport Beach, CA 92660 Phone: 949-836-1690 Fax: 949-640-2090 | |
Wenjing Liu, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 360 San Miguel Dr Ste 410, Newport Beach, CA 92660 Phone: 949-200-6838 | |
Arthur Strick, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 220 Newport Center Dr, Newport Beach, CA 92660 Phone: 949-376-0089 Fax: 949-376-2199 | |
Dr. Lisa D. Garbutt, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 400 Newport Center Dr Ste 404, Newport Beach, CA 92660 Phone: 949-640-2023 Fax: 949-640-7182 | |
Dr. Ehsan Sadri, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 361 Hospital Rd, Suite 327, Newport Beach, CA 92663 Phone: 949-642-3100 Fax: 949-642-4900 | |
Arlene Gwon, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 8 Trafalgar, Newport Beach, CA 92660 Phone: 949-640-8620 Fax: 949-640-6660 | |
Dr. Firooz Rezazadeh Oskooi, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1945 Santiago Dr, Newport Beach, CA 92660 Phone: 949-642-9324 |